Medicine and Dentistry
Maturity Onset Diabetes of the Young
100%
Glucagon Like Peptide 1
100%
Dipeptidyl Peptidase-4 Inhibitor
100%
Dipeptidyl Peptidase IV
66%
Metabolic Clearance
33%
Biological Activity
33%
Gastrointestinal Hormone
33%
Endocrinology
33%
Mediator
33%
Side Effect
33%
Blood Glucose
33%
Patient with Type 2 Diabetes
33%
Therapeutic Agent
33%
Antidiabetic Agent
33%
Keyphrases
Peptide Degradation
100%
Type 2 Diabetes Prevention
100%
Dipeptidyl peptidase-4 (DPP-4)
100%
Glucagon-like
60%
Native Peptides
20%
Design Approach
20%
Type 2 Diabetes Mellitus (T2DM)
20%
Type 2 Diabetic Patients
20%
Metabolic Instability
20%
Therapeutic Agents
20%
Biological Effects
20%
Insulinotropic Effects
20%
Intestinal Hormones
20%
Antidiabetic Drugs
20%
Blood Glucose
20%
Rational Drug Design
20%
Metabolic Clearance
20%
Metabolic Effects
20%
Endocrinology
20%
Pharmacology, Toxicology and Pharmaceutical Science
Dipeptidyl Peptidase IV Inhibitor
100%
Non Insulin Dependent Diabetes Mellitus
100%
Glucagon-Like Peptide-1
100%
Dipeptidyl Peptidase IV
66%
Antidiabetic Agent
33%
Drug Development
33%
Side Effect
33%
Gastrointestinal Hormone
33%
Biochemistry, Genetics and Molecular Biology
Dipeptidyl Peptidase-4
100%
Glucagon-Like Peptide-1
60%
Glucose Blood Level
20%
Metabolic Clearance
20%
Mediator
20%
Biological Activity
20%